FUSETTI, CHIARA
FUSETTI, CHIARA
Universita' degli Studi di MILANO
Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis
2026 D. Moschese, C. Fusetti, S. Lazzarin, A. Giacomelli, V. Mazzotta, D. Cattaneo, A. D'Avolio, F. Caruso, D. Maddalena, F. Petri, A. Antinori, C. Gervasoni, A. Gori, M. Vittoria Cossu
The past that haunts: lessons from missed resistance history
2026 F. Petri, V. Iannone, C. Fusetti, S. Lazzarin, A. Giacomelli, M.V. Cossu, A. Lai, A. Gori, A. Ridolfo, C.F. Perno, C. Gervasoni
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study
2026 G. Del Duca, D. Moschese, M. Maresca, C. Fusetti, R. Esvan, M.V. Cossu, A. Giacinta, S. Lazzarin, V. Barchi, F. Caruso, G. Micheli, C. Gervasoni, A. Giacomelli, A. Antinori, A. Gori, V. Mazzotta
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions
2025 C. Fusetti, E. Caruso, A. Giacomelli, D. Calzavara, M.V. Cossu, N. Frattini, F. Caruso, P. Vinti, C. Atzori, F. Petri, S. Antinori, A. Gori, M. Cernuschi, D. Moschese
Effectiveness and safety of tenofovir alafenamide/emtricitabine/bictegravir as a first-line regimen in people with HIV: A retrospective observational study
2025 A. Giacomelli, M. Vittoria Cossu, D. Moschese, G. Carrozzo, S. Reato, F. Sabaini, G. Pozza, M.L. Colombo, C. Fusetti, A. Lisa Ridolfo, C. Gervasoni, S. Antinori, A. Gori
High effectiveness of ceftriaxone monotherapy and limited value of routine test-of-cure for Gonorrhoea in a low-resistance setting
2025 C. Fusetti, F. Salari, F. Petri, A. Rizzo, A. Giacomelli, A. Cavallo, F. Caruso, L. Morelli, C. Gervasoni, D. Mileto, M. Vittoria Cossu, A. Lombardi, A. Riva, A. Gori, D. Moschese
Neurobrucellosis Presenting with Motor Damage or Hearing Loss, and Use of Steroids are Associated with a Higher Risk of Sequelae or Relapse: A Systematic Review of Individual Participant Data
2024 C. Fusetti, F. Petri, M.H. Murad, S. Merli, R. Giorgi, G. Rizzardini, A. Gori, M. Passerini
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy
2024 A. Rizzo, D. Moschese, F. Salari, A. Giacomelli, L. Morelli, M.V. Cossu, C. Fusetti, F. Petri, G. Casalini, A. Poloni, S. Lazzarin, A. Gori, S. Antinori, M.R. Gismondo, A. Lombardi, G. Rizzardini
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections
2024 A. Rizzo, D. Moschese, F. Salari, A. Giacomelli, A. Cavallo, M.V. Cossu, L. Morelli, C. Fusetti, G. Carrozzo, S. Reato, V. Micheli, S. Antinori, A. Lombardi, A. Gori, M.R. Gismondo
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
2024 D. Cattaneo, M. Fusi, M. Colaneri, C. Fusetti, C. Genovese, R. Giorgi, M. Matone, S. Merli, F. Petri, A. Gori
Detection and typization of HPV genotypes in subjects with oral and upper respiratory tract lesions, Milan, Italy
2024 A. Rizzo, F. Salari, A. Eplite, A. Giacomelli, D. Moschese, D. Dalu, M.V. Cossu, R. Lorusso, G. Pozza, L. Morelli, C. Fasola, C. Tonielli, C. Fusetti, V. De Cristofaro, A. Gori, A. Lombardi, G. Rizzardini, M.R. Gismondo, S. Antinori
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024
2024 D. Moschese, A. Roberto Raccagni, A. Giacomelli, A. Piralla, R. Rossotti, A. Raimondi, D. Tesoro, L. Vezzosi, M. Gulletta, N. Clementi, S. Venturelli, S. Benardon, D. Ricaboni, D. Bernacchia, A. Mancon, F. Rovida, F. Attanasi, D. Cereda, M.R. Gismondo, A. Gori, G. Rizzardini, S. Antinori, F. Baldanti, A.V. Marzano, G. Marchetti, F. Castelli, A. Castagna, S. Nozza, D. Mileto, P. Bonfanti, L. Biasioli, R. Bruno, M. Vittoria Cossu, C. Fusetti, S. Lazzarin, M. Locatelli, M. Morosi, M. Piscaglia, L. Pusterla, G. Pozza, S. Ramoni, S. Rusconi, M. Rizzi, A. Rizzo, F. Sabaini, F. Salari, M. Sampaolo, M. Puoti, M. Tirani, L. Rachele Tomasoni
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient
2023 A. Rizzo, A. Foschi, F. Bracchitta, I. Faggion, F. Salari, F. Borgonovo, C. Fusetti, D. Mileto, G. Rizzardini, A. Lombardi, M.R. Gismondo, V. Micheli
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study
2022 A. Giacomelli, A.L. Ridolfo, L. Pezzati, L. Oreni, G. Carrozzo, M. Beltrami, A. Poloni, B. Caloni, S. Lazzarin, M. Colombo, G. Pozza, S. Pagano, S. Caronni, C. Fusetti, M. Gerbi, F. Petri, F. Borgonovo, F. D'Aloia, C. Negri, G. Rizzardini, S. Antinori
Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials
2021 M. Piscaglia, M. Cossu, M. Passerini, F. Petri, M. Gerbi, C. Fusetti, A. Capetti, G. Rizzardini
Remdesivir in moderate to severe COVID-19 : A matter of time?
2021 C. Bonazzetti, C. Fusetti, M. Gerbi, F. Petri, A. Poloni, S. Antinori, A. Giacomelli, L. Oreni, A.L. Ridolfo, M. Pavia